0000000000354778

AUTHOR

Thomas Noppeney

showing 3 related works from this author

Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous…

2015

AbstractBackgroundThis was a prospective study of radiofrequency segmental thermal ablation (RFA) for the treatment of incompetent varicose great saphenous veins (GSVs). The present report describes long-term follow-up at 5 years.MethodsThe 5-year follow-up of this multicentre European study included assessment of the Venous Clinical Severity Score (VCSS), and GSV occlusion and reflux on duplex imaging.ResultsA total of 225 patients had 295 GSVs treated by RFA, achieving an initial vein occlusion rate of 100 per cent. With 80·0 per cent compliance, Kaplan–Meier analyses showed a GSV occlusion rate of 91·9 per cent and a reflux-free rate of 94·9 per cent at 5 years. Among the 15 GSVs noted w…

medicine.medical_specialtyHot TemperatureRadiofrequency ablationmedicine.medical_treatmentCatheter ablationlaw.inventionVaricose VeinslawVaricose veinsOcclusionmedicineHumansSaphenous VeinProspective StudiesProspective cohort studyUltrasonographybusiness.industryRefluxOriginal ArticlesVein occlusionSurgeryTreatment OutcomeVenous InsufficiencyCatheter AblationSurgerymedicine.symptombusinessCohort studyBritish Journal of Surgery
researchProduct

Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment o…

2011

BackgroundRadiofrequency segmental thermal ablation (RSTA) has become a commonly used technology for occlusion of incompetent great saphenous veins (GSVs). Midterm results and data on clinical parameters are still lacking.MethodsA prospective multicenteral trial monitored 295 RSTA-treated GSVs for 36 months. Clinical control visits included flow and reflux analysis by duplex ultrasound imaging and assessment of clinical parameters according to the CEAP classification and Venous Clinical Severity Score (VCSS).ResultsA total of 256 of 295 treated GSVs (86.4%) were available for 36 months of follow-up. At 36 months, Kaplan-Meier survival analysis showed the probability of occlusion was 92.6% a…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentmedicine.medical_treatmentPainKaplan-Meier EstimateRisk AssessmentSeverity of Illness IndexVaricose VeinsYoung AdultPredictive Value of TestsRisk FactorsOcclusionHumansPain ManagementMedicineSaphenous VeinProspective StudiesVeinProspective cohort studyAgedPain MeasurementUltrasonography Doppler DuplexChi-Square Distributionbusiness.industryVascular diseaseEndovascular ProceduresGreat saphenous veinRefluxMiddle Agedmedicine.diseaseAblationSurgeryEuropeTreatment Outcomemedicine.anatomical_structureRegional Blood FlowPredictive value of testsCatheter AblationFemaleSurgeryCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesJournal of Vascular Surgery
researchProduct

Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).

2021

Objective Management and outcomes of superficial vein thrombosis (SVT) are highly variable and not well described. Therefore, the INvestigating SIGnificant Health TrendS in the management of SVT (INSIGHTS-SVT) study collected prospective data under real life conditions. Methods Prospective observational study of objectively confirmed acute isolated SVT. The primary outcome was a composite of symptomatic deep vein thrombosis (DVT), pulmonary embolism (PE), and extension or recurrence of SVT at three months. The primary safety outcome was clinically relevant bleeding. Results A total of 1 150 patients were included (mean age 60.2 ± 14.7 years; 64.9% women; mean BMI 29.4 ± 6.3 kg/m2). SVT was …

AdultMalemedicine.medical_specialtySuperficial vein thrombosismedicine.drug_classDeep veinLow molecular weight heparinHemorrhage030204 cardiovascular system & hematology030230 surgeryFondaparinuxVaricose Veins03 medical and health sciences0302 clinical medicineRecurrenceRisk FactorsmedicineHumansProspective StudiesAgedAged 80 and overVenous Thrombosisbusiness.industryHazard ratioLeg UlcerAnticoagulantsHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisPulmonary embolismSurgeryVenous thrombosismedicine.anatomical_structureTreatment OutcomeFondaparinuxLower ExtremityVenous InsufficiencySurgeryFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismStockings Compressionmedicine.drugFactor Xa InhibitorsEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
researchProduct